Veru
Veru

Dividends • Veru

VERU

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
4/28/2014
5/7/2014
0,07
Quarterly
1/27/2014
2/5/2014
0,07
Quarterly
10/28/2013
11/6/2013
0,07
Quarterly
7/29/2013
8/7/2013
0,07
Quarterly
4/29/2013
5/8/2013
0,07
Quarterly
1/28/2013
2/6/2013
0,06
Quarterly
10/29/2012
11/7/2012
0,06
Quarterly
7/30/2012
8/8/2012
0,06
Quarterly
4/30/2012
5/9/2012
0,06
Quarterly
1/30/2012
2/9/2012
0,05
Quarterly
10/31/2011
11/9/2011
0,05
Quarterly
7/29/2011
8/9/2011
0,05
Quarterly
4/29/2011
5/10/2011
0,05
Quarterly
1/27/2011
2/7/2011
0,05
Quarterly
11/1/2010
11/10/2010
0,05
Quarterly
8/2/2010
8/11/2010
0,05
Quarterly
1/2